Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Lumen Bioscience
company
About
Lumen Bio discovers, develops, & manufactures biologic drugs and vaccine candidates for several prevalent, worldwide diseases.
- 51 - 100
Highlights
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $1.80M
- Industries
- Biopharma,Biotechnology,Life Science
- Founded date
- Apr 1, 2017
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Lumen Bio is a clinical-stage biotechnology company developing topically and mucosally delivered biologic drugs to treat and prevent highly prevalent diseases.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
4
$33M
Lumen Bioscience has raised a total of
$33M
in funding over 2 rounds. Their latest funding was raised on
Sep 24, 2020 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 24, 2020 | Grant | $4M | 1 |
U.S. Army Medical Research & Development Command
|
— | Detail |
| Sep 1, 2020 | Series B | $16M | 1 | — | — | Detail |
| Dec 5, 2017 | Grant | $1.80M | 1 |
US Department of Energy
|
— | Detail |
| Dec 5, 2017 | Series A | $11.20M | 1 |
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
3
3
Lumen Bioscience is funded by 3 investors.
U.S. Army Medical Research & Development Command
and US Department of Energy
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
U.S. Army Medical Research & Development Command
|
Yes | Grant |
|
US Department of Energy
|
Yes | Grant |
|
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
